Aveanna Healthcare (AVAH) +39% in 30 Days: What’s Behind the Strong Rally?
Key Takeaways
- Aveanna Healthcare (AVAH) climbed roughly 39% over the trailing 30 days, rising from about $9.45 to above $13.
- The move was driven primarily by a stronger-than-expected second-quarter report and a raised full-year outlook announced August 13, 2026.
- Every operating division grew, revenue rose 13.7% year over year, and adjusted EPS of $0.22 beat consensus estimates.
- The stock reached a five-year high as management highlighted a California pediatric nursing rate increase and expanding preferred-payer agreements.
- Over the broader quarter, the shares have advanced approximately 80% from late-May levels near $7.30.
Aveanna Healthcare (AVAH) Company Overview and Market Position
Aveanna Healthcare Holdings Inc. is a diversified home care platform serving medically complex, high-cost patient populations across the United States. The company operates through three segments: Private Duty Services (PDS), which provides private duty nursing and pediatric therapy; Home Health & Hospice (HHH), covering in-home skilled nursing and end-of-life care; and Medical Solutions, which supplies enteral nutrition and related products.
Aveanna's strategy centers on aligning clinical capacity with government payers and managed-care organizations that offer enhanced reimbursement or value-based arrangements. Investors follow the stock closely because of its exposure to rising demand for home and community-based care, its preferred-payer momentum, and its ability to convert reimbursement gains into caregiver capacity and patient volumes. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent Stock Performance: 30 Days and the Broader Quarter
Over the last 30 days, AVAH shares climbed from a closing price of $9.45 on July 24, 2026, to roughly $13.16 by August 21, 2026, a gain of approximately 39%. The advance accelerated sharply after the company reported second-quarter results on August 13, when the stock jumped from around $9 to above $11 in a single session and continued higher into the mid-$13 range.
The quarterly trend is even more pronounced. From late-May levels near $7.30, the shares have risen approximately 80%, recovering from a brief pullback into the low-$6 range in early June before staging a sustained rally. The result is a multi-month uptrend in which the stock has set a five-year high.
What Drove AVAH Stock in the Last 30 Days
The primary catalyst was the company's second-quarter report. Aveanna posted revenue of $670.5 million, up 13.7% year over year, while net income rose to $40.3 million from $27.0 million a year earlier. Adjusted earnings per share of $0.22 exceeded consensus estimates of $0.17, and adjusted EBITDA increased 8% to $95.4 million. All three operating divisions expanded, led by 14.8% growth in Home Health & Hospice and 14.0% growth in Private Duty Services.
Management also raised full-year guidance, lifting the revenue outlook to more than $2.68 billion and the adjusted EBITDA outlook to more than $365 million. Investors responded to several forward-looking developments, including a California 2027 budget provision for a meaningful pediatric private duty nursing rate increase effective January 1, 2027, the addition of three preferred-payer agreements in Private Duty Services, and progress on the Family First Homecare acquisition integration. The shares reached a five-year high amid the announcement.
What Drove AVAH Stock Performance Over the Last Quarter
The quarterly rally reflects a broader shift in how the market values Aveanna's operating turnaround. After years of contending with caregiver shortages and reimbursement pressure, the company has demonstrated sustained organic growth across all three segments and improved profitability. The closing of the Family First Homecare acquisition in early June, a repricing of its credit facility, and a steady expansion of preferred-payer agreements across each division reinforced confidence in the growth strategy.
Institutional positioning has also strengthened, with the number of hedge funds holding the stock increasing during the quarter. The combination of raised guidance, rate-relief visibility in California, and improving caregiver capacity has supported a re-rating of the shares from single-digit to double-digit levels over the three-month period.
Key Factors to Watch Going Forward
Several factors are likely to shape AVAH's trajectory in the coming months. Investors will monitor final details from California's Medi-Cal department on the pediatric private duty nursing rate increase, expected before the end of September, along with any additional state rate enhancements from pending budget cycles. Wage pass-throughs to caregivers and their effect on Private Duty Services gross margin will be an important operational signal.
The pace of preferred-payer agreement additions across all three segments, the Family First integration timeline, and progress toward the company's leverage target of below three times also warrant attention. Macroeconomic factors such as labor market conditions and interest rates remain relevant given Aveanna's variable-rate debt. These elements will be central to evaluating whether the recent momentum can be sustained. From what I see, this is important because it could determine how durable the re-rating proves to be.
Exploring AI-Powered Trading Strategies
I’ve found Tickeron’s Trending AI Robots page useful when looking for additional context on market moves like this one. It highlights a curated selection of AI-powered trading bots drawn from a platform that offers hundreds of bots trading thousands of tickers. Only the top-performing and most relevant bots appear in this section, giving traders a streamlined view of active strategies across the market. The featured bots vary in trading style, holding timeframe, and performance metrics, so investors can evaluate approaches that align with different risk profiles and objectives. Exploring the page can help traders identify automated strategies and tools worth monitoring alongside their own research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Aroon Indicator for AVAH shows an upward move is likely
AVAH's Aroon Indicator triggered a bullish signal on September 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 175 similar instances where the Aroon Indicator showed a similar pattern. In 142 of the 175 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAH advanced for three days, in 196 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The 10-day RSI Indicator for AVAH moved out of overbought territory on September 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Momentum Indicator moved below the 0 level on September 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVAH as a result. In 82 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for AVAH turned negative on September 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 35 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
AVAH broke above its upper Bollinger Band on September 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. AVAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.363) is normal, around the industry mean (208.357). P/E Ratio (10.849) is within average values for comparable stocks, (175.235). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.492). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.223) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement